Multicenter randomized phase III study of the cardioprotective effect of dexrazoxane (Cardioxane®) in advanced/metastatic breast cancer patients treated with anthracycline-based chemotherapyM. Marty, V. Stahalova, Bernardo L. Rapoport et al.|Annals of Oncology|2006Cited by 197
2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomitingJørn Herrstedt, Florian Scotté, Rebecca Clark-Snow et al.|ESMO Open|2024Cited by 141